Delphi Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$581K Sell
6,169
-10
-0.2% -$998 0.7% 69
2025
Q4
$610K Sell
6,179
-708
-10% -$68.5K 0.59% 69
2025
Q3
$584K Sell
6,887
-45
-0.6% -$3.56K 0.54% 74
2025
Q2
$472K Sell
6,932
-484
-7% -$30.7K 0.46% 76
2025
Q1
$449K Sell
7,416
-1,367
-16% -$95.3K 0.46% 76
2024
Q4
$607K Buy
8,783
+7,583
+632% +$540K 0.59% 70
2024
Q3
$79K Hold
1,200
0.07% 87
2024
Q2
$73K Buy
+1,200
New +$68K 0.06% 80

Other funds holding INCY

Delphi Management's INCY Position: Q1 2026 in Review

Delphi Management reduced its Incyte (INCY) stake by 0.16% in Q1 2026, selling an estimated $998 and leaving 6,169 shares worth $581K. The position accounts for 0.7% of the portfolio, ranked #69.

Delphi Management first reported a position in INCY in Q2 2024 and has held it in 8 quarters since. The position peaked at $610K in Q4 2025. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Delphi Management held 6,169 shares of Incyte worth $581K as of Q1 2026.
  • Delphi Management sold 10 Incyte shares in Q1 2026, an estimated $998.
  • Incyte made up 0.7% of Delphi Management's portfolio in Q1 2026, its #69 holding.
  • Delphi Management first reported a position in Incyte in Q2 2024 and has held it in 8 quarters since.
  • Delphi Management's Incyte position peaked at $610K in Q4 2025.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Delphi Management's 13F filing for Q1 2026, filed 20 Apr 2026.